Unknown

Dataset Information

0

Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139.

ABSTRACT: GPR139 is an orphan G-protein coupled receptor (GPCR) which is primarily expressed in the central nervous system (CNS). In order to explore the biological function of this receptor, selective tool compounds are required. A screening campaign identified compound 1a as a high potency GPR139 agonist with an EC50 = 39 nM in a calcium mobilization assay in CHO-K1 cells stably expressing the GPR139 receptor. In the absence of a known endogenous ligand, the maximum effect was set as 100% for 1a. Screening against 90 diverse targets revealed no cross-reactivity issues. Assessment of the pharmacokinetic properties showed limited utility as in vivo tool compound in rat with a poor whole brain exposure of 61 ng/g and a brain/plasma (b/p) ratio of 0.03. Attempts to identify a more suitable analogue identified the des-nitrogen analogue 1s with a reduced polar surface area of 76.7 Å(2) and an improved b/p ratio of 2.8. The whole brain exposure remained low at 95 ng/g due to a low plasma exposure.

SUBMITTER: Shi F 

PROVIDER: S-EPMC4028000 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139.

Shi Feng F   Shen Jing Kang JK   Chen Danqi D   Fog Karina K   Thirstrup Kenneth K   Hentzer Morten M   Karlsson Jens-Jakob JJ   Menon Veena V   Jones Kenneth A KA   Smith Kelli E KE   Smith Garrick G  

ACS medicinal chemistry letters 20110228 4

GPR139 is an orphan G-protein coupled receptor (GPCR) which is primarily expressed in the central nervous system (CNS). In order to explore the biological function of this receptor, selective tool compounds are required. A screening campaign identified compound 1a as a high potency GPR139 agonist with an EC50 = 39 nM in a calcium mobilization assay in CHO-K1 cells stably expressing the GPR139 receptor. In the absence of a known endogenous ligand, the maximum effect was set as 100% for 1a. Screen  ...[more]

Similar Datasets

Unknown Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.
| S-EPMC7549263 | biostudies-literature
Unknown Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
| S-EPMC4025658 | biostudies-literature
Unknown Discovery and characterization of novel small molecule agonists of G protein-coupled receptor 119.
| S-EPMC4813729 | biostudies-other
Unknown Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2.
| S-EPMC6580541 | biostudies-literature
Unknown Cryo-EM structure of orphan G protein-coupled receptor GPR21.
| S-EPMC9877262 | biostudies-literature
Unknown Covalent agonists for studying G protein-coupled receptor activation.
| S-EPMC4115510 | biostudies-literature
Unknown Discovery of G Protein-Biased EP2 Receptor Agonists.
| S-EPMC4789666 | biostudies-literature
Unknown SAR Studies of N-[2-(1H-Tetrazol-5-yl)phenyl]benzamide Derivatives as Potent G Protein-Coupled Receptor-35 Agonists.
| S-EPMC5949814 | biostudies-other
Unknown Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1.
| S-EPMC4382091 | biostudies-literature
Unknown Discovery and validation of novel peptide agonists for G-protein-coupled receptors.
| S-EPMC3259865 | biostudies-literature